An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Executives On The Move will be running to a monthly schedule from now, with this edition covering medtech's executive changes for April.

CEO of Japanese ophthalmology specialist lays out clear-sighted business vision as track laid for expansion into global markets and new indications amid expiry challenges at home. New modalities are also being explored to meet needs in demanding disorders, Shigeo Taniuchi tells Scrip in an exclusive interview. 

Evolving challenges will keep the COVID-19 pipeline active, while oncology, immunology and CNS are areas also expected to see much progress in 2022. Industry executives look forward to the year in therapeutic R&D.